Tamoxifen

Tamoxifen works by occupying estrogen receptors on breast cells — essentially blocking estrogen from attaching and signaling those cells to grow. Because many breast cancers are fueled by estrogen, this blocking action can significantly reduce the risk of cancer returning after treatment, or help prevent a first diagnosis in women at elevated risk.

It is typically taken as a daily pill for five to ten years, depending on your individual situation. Research has consistently shown that longer courses of tamoxifen provide greater protection against recurrence for women with hormone-receptor-positive breast cancer. It can be used before menopause, after menopause, or in men with breast cancer.

Like all medications, tamoxifen can have side effects. Hot flashes and changes in menstrual cycles are common. More rare but important considerations include a small increased risk of blood clots and uterine changes, which is why regular check-ins with your healthcare team are an important part of taking it. Understanding both the benefits and risks helps you and your provider make decisions that are right for your specific situation.

Tamoxifen is one of the most studied and widely used treatments in breast cancer care. Decades of clinical research have confirmed that it meaningfully reduces the risk of cancer recurrence and improves long-term survival in people with hormone-receptor-positive breast cancer. It also plays a role in chemoprevention — reducing the likelihood of a first breast cancer in high-risk individuals.

If your pathology report showed that your breast cancer is estrogen-receptor-positive or progesterone-receptor-positive, tamoxifen may be part of the treatment conversation. Knowing how it works helps you understand why your team may recommend continuing it for years beyond initial treatment, even when you feel well.